Novel Finding on Memory T Cells May Provide Boost to Cancer Immunotherapy

Scientists report that they have shown conclusively that memory T cells responsible for long-term immune protection arise from effector CD8 T cells. The finding provides insight that should help researchers design more effective vaccines and expand cancer immunotherapies by aiding efforts to harness the immune cells to prevent or cure diseases.The study ( “Effector CD8 T cells dedifferentiate into long-lived memory cells ”) appears in Nature . Researchers at St. Jude C